{"url_path":"/sec/cvsi/10-q/2026/cover-page","section_key":"cover-page","section_title":"Cover Page","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1510964/0001193125-26-226702-index.html","accession_number":"0001193125-26-226702","cik":"0001510964","ticker":"CVSI","issuer_name":"CV Sciences, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1510964/0001193125-26-226702-index.html","primary_entity_key":"0001510964","primary_entity_name":"CV Sciences, Inc."},"word_count":568,"has_tables":true,"body_markdown":"10-Q\n\nQ1P56D0001510964false--12-31http://fasb.org/us-gaap/2025#ProductMemberhttp://fasb.org/us-gaap/2025#ProductMemberhttp://fasb.org/srt/2025#ChiefExecutiveOfficerMemberOneOne0001510964us-gaap:RetainedEarningsMember2024-12-310001510964cvsi:ECommMember2025-01-012025-03-310001510964us-gaap:DebtInstrumentRedemptionPeriodOneMember2025-09-012025-09-300001510964us-gaap:EmployeeStockOptionMember2025-01-012025-03-310001510964cvsi:WarsawFacilityMember2024-10-012024-10-3100015109642026-05-110001510964cvsi:AmendedNotesMembersrt:MaximumMember2026-03-042026-03-0400015109642025-01-012025-03-310001510964us-gaap:SubsequentEventMembercvsi:AprilAmendmentMember2026-04-090001510964us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-12-310001510964us-gaap:ConvertibleNotesPayableMember2026-03-310001510964us-gaap:TradeNamesMember2026-01-012026-03-3100015109642024-12-310001510964cvsi:SecuredPromissoryNoteMember2025-02-280001510964us-gaap:PerformanceSharesMember2026-01-012026-03-310001510964cvsi:StreetervilleCapitalLLCMembercvsi:ConvertiblePromissoryNotesMember2025-01-012025-03-310001510964us-gaap:FairValueInputsLevel1Member2025-12-310001510964cvsi:WarsawFacilityMember2024-10-010001510964us-gaap:PrepaidExpensesAndOtherCurrentAssetsMembercvsi:FormerPresidentandCEOMember2019-06-300001510964us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-12-310001510964cvsi:A2023EquityIncentivePlanMember2025-12-310001510964us-gaap:TradeNamesMember2026-03-310001510964cvsi:FormerPresidentandCEOMember2025-01-012025-03-3100015109642025-03-310001510964cvsi:WarsawFacilityMember2024-10-310001510964us-gaap:EmployeeStockOptionMember2026-01-012026-03-310001510964us-gaap:EmployeeStockOptionMember2019-01-012019-12-310001510964cvsi:ThirdNoteMember2026-01-012026-03-310001510964us-gaap:RetainedEarningsMember2025-03-310001510964us-gaap:EmployeeStockOptionMembercvsi:FormerPresidentandCEOMember2025-12-310001510964us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-01-012026-03-310001510964cvsi:RetailNaturalProductsAndOtherMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2025-01-012025-03-310001510964cvsi:AmendedNotesMember2026-01-012026-03-3100015109642026-03-310001510964us-gaap:AdditionalPaidInCapitalMember2026-01-012026-03-310001510964cvsi:GrandJunctionFacilityMemberstpr:CO2025-02-280001510964us-gaap:NotesPayableOtherPayablesMember2025-10-3100015109642025-09-012025-09-300001510964us-gaap:RetainedEarningsMember2026-03-310001510964cvsi:SecuredPromissoryNoteMember2025-10-012025-10-310001510964us-gaap:CommonStockMember2025-03-310001510964cvsi:FormerPresidentandCEOMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2019-01-012019-12-310001510964us-gaap:PrepaidExpensesAndOtherCurrentAssetsMembercvsi:FormerPresidentandCEOMember2020-12-310001510964us-gaap:EmployeeStockOptionMembercvsi:FormerPresidentandCEOMember2024-01-012024-12-310001510964cvsi:AmendedNotesMember2026-03-040001510964us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2026-01-012026-03-310001510964cvsi:AmendedNotesMembersrt:MinimumMembercvsi:SeniorSecuredConvertibleNoteMember2026-03-040001510964cvsi:A2023EquityIncentivePlanMember2023-06-0100015109642026-01-012026-03-310001510964us-gaap:RestrictedStockUnitsRSUMember2019-01-012019-12-310001510964cvsi:FirstInsuranceFundingMember2025-12-310001510964us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-03-310001510964us-gaap:SalesRevenueNetMembercvsi:ECommMemberus-gaap:ProductConcentrationRiskMember2025-01-012025-03-310001510964us-gaap:TradeNamesMember2025-12-310001510964us-gaap:FairValueInputsLevel1Member2026-03-310001510964us-gaap:PerformanceSharesMember2025-01-012025-03-310001510964cvsi:FinanceAgreementOctoberTwentyTwentyFourMembercvsi:UnsecuredNotePayableMember2026-03-310001510964cvsi:AmendedNotesMemberus-gaap:CommonStockMember2026-03-040001510964cvsi:FormerPresidentandCEOMember2023-01-012023-03-310001510964srt:MinimumMembercvsi:SeniorSecuredConvertibleNoteMembercvsi:ThirdNoteMember2026-03-040001510964us-gaap:NotesPayableOtherPayablesMember2026-01-012026-03-3100015109642025-01-012025-12-310001510964cvsi:OptionsOutsideTheAmended2013PlanAnd2023EquityIncentivePlanMember2026-03-310001510964us-gaap:NotesPayableOtherPayablesMembercvsi:StreetervilleCapitalLLCMember2024-07-310001510964cvsi:RetailNaturalProductsAndOtherMember2026-01-012026-03-310001510964cvsi:AmendedNotesMember2026-03-310001510964us-gaap:NotesPayableOtherPayablesMember2025-02-012025-02-280001510964us-gaap:FairValueInputsLevel2Member2025-12-310001510964us-gaap:EmployeeStockOptionMembercvsi:FormerPresidentandCEOMember2019-01-012019-12-310001510964cvsi:UnsecuredNotePayableMembercvsi:FirstInsuranceFundingMember2026-03-310001510964us-gaap:DebtInstrumentRedemptionPeriodThreeMember2025-09-012025-09-300001510964us-gaap:NotesPayableOtherPayablesMember2025-02-280001510964cvsi:UnsecuredNotePayableMembercvsi:FirstInsuranceFundingMember2024-10-310001510964us-gaap:ConvertibleNotesPayableMember2026-01-012026-03-310001510964us-gaap:FairValueInputsLevel3Member2026-03-310001510964cvsi:ThirdNoteMember2026-03-042026-03-040001510964us-gaap:NotesPayableOtherPayablesMember2025-10-012025-10-310001510964cvsi:A2023EquityIncentivePlanMember2023-06-012023-06-010001510964us-gaap:FairValueInputsLevel3Member2025-12-310001510964us-gaap:RetainedEarningsMember2025-01-012025-03-310001510964srt:MinimumMemberus-gaap:NotesPayableOtherPayablesMember2026-03-310001510964cvsi:GrandJunctionFacilityMemberstpr:CO2025-02-012025-02-280001510964us-gaap:AccruedLiabilitiesMembercvsi:FormerPresidentandCEOMember2022-12-310001510964cvsi:UnsecuredNotePayableMembercvsi:FirstInsuranceFundingMember2025-10-310001510964us-gaap:RetainedEarningsMember2026-01-012026-03-310001510964cvsi:AmendedNotesMember2026-03-042026-03-040001510964us-gaap:RestrictedStockUnitsRSUMembercvsi:FormerPresidentandCEOMember2019-01-012019-12-310001510964us-gaap:WarrantMember2026-01-012026-03-310001510964cvsi:FormerPresidentandCEOMember2023-01-012023-12-310001510964cvsi:UnsecuredNotePayableMembercvsi:FirstInsuranceFundingMember2024-10-012024-10-310001510964us-gaap:CustomerRelationshipsMember2026-01-012026-03-310001510964us-gaap:CommonStockMember2025-12-310001510964us-gaap:EmployeeStockOptionMembercvsi:FormerPresidentandCEOMember2024-12-310001510964cvsi:A2023EquityIncentivePlanMember2026-01-012026-01-010001510964us-gaap:NotesPayableOtherPayablesMember2025-12-310001510964us-gaap:AdditionalPaidInCapitalMember2025-01-012025-03-310001510964us-gaap:AdditionalPaidInCapitalMember2024-12-310001510964us-gaap:RetainedEarningsMember2025-12-310001510964us-gaap:FairValueInputsLevel2Member2026-03-310001510964cvsi:ThirdNoteMember2026-03-310001510964us-gaap:CustomerRelationshipsMember2026-03-310001510964cvsi:RetailNaturalProductsAndOtherMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2026-01-012026-03-310001510964us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-03-310001510964cvsi:RetailNaturalProductsAndOtherMember2025-01-012025-03-310001510964srt:MinimumMembercvsi:FormerPresidentandCEOMember2025-02-122025-02-120001510964us-gaap:DebtInstrumentRedemptionPeriodTwoMember2025-09-012025-09-300001510964cvsi:FirstInsuranceFundingMember2026-03-310001510964us-gaap:SubsequentEventMembercvsi:AprilAmendmentMember2026-04-092026-04-0900015109642025-12-310001510964us-gaap:NotesPayableOtherPayablesMembercvsi:StreetervilleCapitalLLCMember2024-07-012024-07-310001510964cvsi:SecuredPromissoryNoteMembercvsi:StreetervilleCapitalLLCMember2022-08-012022-08-310001510964us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-01-012025-03-310001510964us-gaap:EmployeeStockOptionMembercvsi:FormerPresidentandCEOMember2016-07-012016-07-310001510964us-gaap:CustomerRelationshipsMember2025-12-310001510964us-gaap:CommonStockMember2026-03-310001510964cvsi:SecuredPromissoryNoteMember2025-02-012025-02-280001510964us-gaap:ConvertibleNotesPayableMember2025-12-310001510964us-gaap:AdditionalPaidInCapitalMember2025-03-310001510964cvsi:FormerPresidentandCEOMember2019-12-310001510964us-gaap:EmployeeStockOptionMembercvsi:FormerPresidentandCEOMember2017-03-012017-03-310001510964cvsi:SecuredPromissoryNoteMembercvsi:StreetervilleCapitalLLCMember2024-07-012024-07-310001510964us-gaap:AdditionalPaidInCapitalMember2025-12-310001510964us-gaap:NotesPayableOtherPayablesMember2026-03-310001510964stpr:CAcvsi:SanDiegoFacilityMember2025-05-012025-05-310001510964cvsi:SecuredPromissoryNoteMember2025-10-310001510964us-gaap:CommonStockMember2026-01-012026-03-310001510964us-gaap:WarrantMember2025-01-012025-03-310001510964us-gaap:CommonStockMember2024-12-310001510964stpr:CAcvsi:SanDiegoFacilityMember2025-05-310001510964cvsi:UnsecuredNotePayableMembercvsi:FirstInsuranceFundingMember2025-10-012025-10-310001510964us-gaap:AdditionalPaidInCapitalMember2026-03-310001510964us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2025-01-012025-03-310001510964cvsi:ECommMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2026-01-012026-03-310001510964cvsi:ECommMember2026-01-012026-03-31iso4217:USDxbrli:sharesxbrli:pureutr:sqftxbrli:sharescvsi:Segmentiso4217:USD\n\n \n\nUNITED STATES\n\nSECURITIES AND EXCHANGE COMMISSION\n\nWASHINGTON, D.C. 20549\n\nFORM 10-Q\n\n☒\n\nQuarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934\n\n \n\nFor the quarterly period ended March 31, 2026\n\n \n\n☐\n\nTransition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934\n\n \n\nFor the transition period from _________ to ________\n\nCommission File Number: 000-54677\n\nCV Sciences, Inc.\n\n(Exact name of registrant as specified in its charter)\n\n \n\nDelaware\n\n80-0944970\n\n(State or other jurisdiction of incorporation or organization)\n\n(I.R.S. Employer Identification No.)\n\n9530 Padgett Street, Suite 107\n\nSan Diego, CA 92126\n\n(Address of principal executive offices)\n\n(866) 290-2157\n\n(Registrant’s telephone number, including area code)\n\nN/A\n\n(Former name, former address and former fiscal year, if changed since last report)\n\n \n\nSecurities registered pursuant to Section 12(b) of the Act:\n\n \n\nTitle of each class\n\nTrading symbol(s)\n\nName of each exchange on which registered\n\nNone\n\n \n\n \n\nIndicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ý No o\n\nIndicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ý No o\n\nIndicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.\n\n \n\nLarge accelerated filer\n\n☐\n\nAccelerated filer\n\n☐\n\nNon-accelerated filer\n\n☒\n\nSmaller reporting company\n\n☒\n\n \n\n \n\nEmerging growth company\n\n☐\n\nIf an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐\n\nIndicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒\n\nAs of May 11, 2026, the issuer had 203,977,528 shares of issued and outstanding common stock, par value $0.0001 per share.\n\n \n\n \n\n \n\n \n\nCV SCIENCES, INC.\n\nFORM 10-Q\n\nTABLE OF CONTENTS\n\n \n\nPAGE\n\n[PART I – FINANCIAL INFORMATION](#part_i_financial_information)\n\n[Item 1.](#item_1_financial_statements)\n\n[Financial Statements (unaudited)](#item_1_financial_statements)\n\n1\n\n[Condensed Consolidated Balance Sheets](#condensed_balance_sheets)\n\n1\n\n[Condensed Consolidated Statements of Operations](#condensed_statements_of_operations)\n\n2\n\n \n\n[Condensed Consolidated Statements of Comprehensive Loss](#condensed_statements_of_compr)\n\n3\n\n[Condensed Consolidated Statements of Stockholders’ Equity](#condensed_statements_of_stockholders)\n\n4\n\n[Condensed Consolidated Statements of Cash Flows](#condensed_statements_of_cash_flows)\n\n5\n\n[Notes to Condensed Consolidated Financial Statements](#notes_to_condensed_financial_statements)\n\n6\n\n[Item 2.](#item_2_managements_discussion)\n\n[Management’s Discussion and Analysis of Financial Condition and Results of Operations](#item_2_managements_discussion)\n\n18\n\n[Item 3.](#item_3_quantitative_and_qualitative)\n\n[Quantitative and Qualitative Disclosure About Market Risk](#item_3_quantitative_and_qualitative)\n\n26\n\n[Item 4.](#item_4_controls_and_procedures)\n\n[Controls and Procedures](#item_4_controls_and_procedures)\n\n27\n\n \n\n[PART II – OTHER INFORMATION](#part_ii_other_information)\n\n \n\n \n\n[Item 1.](#item_1_legal_proceedings)\n\n[Legal Proceedings](#item_1_legal_proceedings)\n\n28\n\n[Item 1A.](#item_1a_risk_factors)\n\n[Risk Factors](#item_1a_risk_factors)\n\n28\n\n[Item 2.](#item_2_unregistered_sales_of_equity)\n\n[Unregistered Sales of Equity Securities and Use of Proceeds](#item_2_unregistered_sales_of_equity)\n\n28\n\n[Item 3.](#item_3_defaults_upon_senior)\n\n[Defaults Upon Senior Securities](#item_3_defaults_upon_senior)\n\n28\n\n[Item 4.](#item_4_mine_safety_disclosures)\n\n[Mine Safety Disclosure](#item_4_mine_safety_disclosures)\n\n28\n\n[Item 5.](#item_5_other_information)\n\n[Other Information](#item_5_other_information)\n\n28\n\n[Item 6.](#item_6_exhibits)\n\n[Exhibits](#item_6_exhibits)\n\n29\n\n \n\n[SIGNATURES](#signatures)\n\n31\n\n \n\n \n\ni\n\n \n\nPART I – FINANCIAL INFORMATION"}